Skip to main content
Basel Medical Group Ltd logo

Basel Medical Group Ltd — Investor Relations & Filings

Ticker · BMGL ISIN · VGG0864B1031 LEI · 529900I1F9NKYIFYQU86 US Human health and social work activities
Open in API
Filings indexed 58 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country VG Virgin Islands (British)
Listing US BMGL

About Basel Medical Group Ltd

https://www.baselmedical.com

Basel Medical Group Ltd. operates as an integrated healthcare provider focused on building a comprehensive ecosystem of medical services. The company's core specializations include orthopedic and neurosurgical care, encompassing sports medicine, trauma services, and post-operative rehabilitation. It aims to function as a single-source provider for musculoskeletal-related treatments. In addition to its specialist services, the group provides general medical care through family clinics and health screening programs. The organization emphasizes a patient-first approach, leveraging advanced medical technology and a commitment to continuous research and development to improve patient outcomes.

Recent filings

Filing Released Lang Actions
6-K - Basel Medical Group Ltd (0002004489) (Filer)
Regulatory Filings
2026-03-30 English
6-K - Basel Medical Group Ltd (0002004489) (Filer)
Regulatory Filings
2026-03-24 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a press release about receipt of a delinquency notification from Nasdaq. The document is short (1330 characters) and primarily serves as a regulatory filing to inform about a specific event rather than a full financial report or detailed disclosure. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2026-01-23 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It provides an explanatory note about the acquisition of Bethesda Medical Pte. Ltd. by Basel Medical Group Ltd, including details of the transaction and payment. The document is relatively short (2251 characters) and primarily serves as an announcement of a corporate event (an acquisition) rather than a full financial report or detailed merger filing. It does not contain comprehensive financial statements or detailed merger/takeover bid documents. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-21 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release about receipt of a delinquency notification from Nasdaq. The document is short (1331 characters) and primarily serves as a regulatory announcement rather than a full financial report or detailed filing. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents.
2025-12-01 English
20-F
Annual Report FY 2025
2025-11-17 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.